Particle.news

Download on the App Store

Anne Wojcicki’s Nonprofit Wins Bid to Acquire 23andMe for $305 Million

The purchase now hinges on Missouri bankruptcy court approval, with attorneys general suing to halt the sale of genetic data without customer consent.

Overview

  • Anne Wojcicki’s nonprofit TTAM Research Institute submitted a $305 million bid to acquire substantially all of 23andMe’s assets, surpassing Regeneron Pharmaceuticals’ earlier $256 million offer.
  • A hearing on June 17 in the U.S. Bankruptcy Court for the Eastern District of Missouri will determine whether the deal moves forward.
  • Twenty-eight state attorneys general led by New York’s Letitia James filed suit to block the sale of customers’ genetic data without explicit consent.
  • TTAM Research Institute pledged to honor 23andMe’s privacy policies, let customers delete their data or opt out of research and form a Consumer Privacy Advisory Board within 90 days of closing.
  • Since 23andMe’s Chapter 11 filing in March, about 1.9 million customers—around 15 percent—have requested deletion of their genetic information.